GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Qiagen NV (NYSE:QGEN) » Definitions » Beneish M-Score

QGEN (Qiagen NV) Beneish M-Score : -2.71 (As of Dec. 14, 2024)


View and export this data going back to 1996. Start your Free Trial

What is Qiagen NV Beneish M-Score?

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -2.71 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for Qiagen NV's Beneish M-Score or its related term are showing as below:

QGEN' s Beneish M-Score Range Over the Past 10 Years
Min: -2.88   Med: -2.61   Max: -2.25
Current: -2.71

During the past 13 years, the highest Beneish M-Score of Qiagen NV was -2.25. The lowest was -2.88. And the median was -2.61.


Qiagen NV Beneish M-Score Historical Data

The historical data trend for Qiagen NV's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Qiagen NV Beneish M-Score Chart

Qiagen NV Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Beneish M-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2.30 -2.41 -2.61 -2.75 -2.26

Qiagen NV Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.30 -2.26 -2.44 -2.48 -2.71

Competitive Comparison of Qiagen NV's Beneish M-Score

For the Diagnostics & Research subindustry, Qiagen NV's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Qiagen NV's Beneish M-Score Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Qiagen NV's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Qiagen NV's Beneish M-Score falls into.



Qiagen NV Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Qiagen NV for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 1.0513+0.528 * 1.3079+0.404 * 0.8891+0.892 * 1.0062+0.115 * 1.0556
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 0.962+4.679 * -0.07135-0.327 * 1.2318
=-2.71

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Sep24) TTM:Last Year (Sep23) TTM:
Total Receivables was $346 Mil.
Revenue was 501.869 + 496.347 + 458.796 + 509.162 = $1,966 Mil.
Gross Profit was 308.307 + 34.764 + 290.989 + 316.1 = $950 Mil.
Total Current Assets was $2,454 Mil.
Total Assets was $6,270 Mil.
Property, Plant and Equipment(Net PPE) was $760 Mil.
Depreciation, Depletion and Amortization(DDA) was $209 Mil.
Selling, General, & Admin. Expense(SGA) was $569 Mil.
Total Current Liabilities was $1,129 Mil.
Long-Term Debt & Capital Lease Obligation was $1,365 Mil.
Net Income was 98.056 + -183.46 + 80.673 + 97.664 = $93 Mil.
Non Operating Income was -11.161 + -69.084 + -3.421 + -9.434 = $-93 Mil.
Cash Flow from Operations was 182.347 + 166.617 + 133.078 + 151.368 = $633 Mil.
Total Receivables was $327 Mil.
Revenue was 475.894 + 494.857 + 485.398 + 497.984 = $1,954 Mil.
Gross Profit was 297.96 + 312.152 + 307.476 + 317.524 = $1,235 Mil.
Total Current Assets was $1,962 Mil.
Total Assets was $5,907 Mil.
Property, Plant and Equipment(Net PPE) was $706 Mil.
Depreciation, Depletion and Amortization(DDA) was $208 Mil.
Selling, General, & Admin. Expense(SGA) was $587 Mil.
Total Current Liabilities was $524 Mil.
Long-Term Debt & Capital Lease Obligation was $1,382 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(345.581 / 1966.174) / (326.69 / 1954.133)
=0.175763 / 0.167179
=1.0513

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(1235.112 / 1954.133) / (950.16 / 1966.174)
=0.632051 / 0.483253
=1.3079

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (2454.073 + 759.932) / 6270.197) / (1 - (1962.39 + 706.02) / 5906.698)
=0.487416 / 0.54824
=0.8891

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=1966.174 / 1954.133
=1.0062

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(208.438 / (208.438 + 706.02)) / (209.286 / (209.286 + 759.932))
=0.227936 / 0.215933
=1.0556

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(568.601 / 1966.174) / (587.425 / 1954.133)
=0.289192 / 0.300606
=0.962

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((1364.584 + 1128.568) / 6270.197) / ((1382.359 + 524.371) / 5906.698)
=0.397619 / 0.322808
=1.2318

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(92.933 - -93.1 - 633.41) / 6270.197
=-0.07135

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Qiagen NV has a M-score of -2.71 suggests that the company is unlikely to be a manipulator.


Qiagen NV Beneish M-Score Related Terms

Thank you for viewing the detailed overview of Qiagen NV's Beneish M-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Qiagen NV Business Description

Address
Hulsterweg 82, Venlo, LI, NLD, 5912 PL
Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (52% of 2023 sales), followed by EMEA (32%), and the Asia-Pacific (16%).
Executives
Prof. Dr. Elaine R. Mardis Supervisory Board
Roland Sackers Board of Directors
Thierry Bernard Board of Directors
Lawrence A. Rosen Supervisory Board